These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||||||||
|
|
|
|
||||||||||||
|
|
☒ | Accelerated filer | ☐ | ||||||||
| Non-accelerated filer | ☐ | Smaller reporting company |
|
||||||||
| Emerging growth company |
|
||||||||||
| TABLE OF CONTENTS | |||||||||||
|
Page
|
|||||||||||
| Assets | October 7, 2023 | December 31, 2022 | |||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
|||||||
| Receivables, net |
|
|
|||||||||
| Inventories, net |
|
|
|||||||||
| Other current assets |
|
|
|||||||||
| Total current assets |
|
|
|||||||||
|
Property and equipment, net of accumulated depreciation of $
|
|
|
|||||||||
| Operating lease right-of-use assets |
|
|
|||||||||
| Goodwill |
|
|
|||||||||
| Other intangible assets, net |
|
|
|||||||||
| Other assets |
|
|
|||||||||
| Total assets | $ |
|
$ |
|
|||||||
| Liabilities and Stockholders’ Equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ |
|
$ |
|
|||||||
| Accrued expenses |
|
|
|||||||||
| Current portion of long-term debt |
|
|
|||||||||
| Other current liabilities |
|
|
|||||||||
| Total current liabilities |
|
|
|||||||||
| Long-term debt |
|
|
|||||||||
| Noncurrent operating lease liabilities |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
| Other long-term liabilities |
|
|
|||||||||
| Total liabilities |
|
|
|||||||||
| Stockholders’ equity: | |||||||||||
|
Preferred stock, nonvoting, $
|
|
|
|||||||||
|
Common stock, voting, $
|
|
|
|||||||||
| Additional paid-in capital |
|
|
|||||||||
| Treasury stock, at cost |
(
|
(
|
|||||||||
| Accumulated other comprehensive loss |
(
|
(
|
|||||||||
| Retained earnings |
|
|
|||||||||
| Total stockholders’ equity |
|
|
|||||||||
| Total liabilities and stockholders’ equity | $ |
|
$ |
|
|||||||
| Twelve Weeks Ended | Forty Weeks Ended | ||||||||||||||||||||||
| October 7, 2023 | October 8, 2022 | October 7, 2023 | October 8, 2022 | ||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Cost of sales,
including purchasing and warehousing costs
|
|
|
|
|
|||||||||||||||||||
| Gross profit |
|
|
|
|
|||||||||||||||||||
| Selling, general and administrative expenses |
|
|
|
|
|||||||||||||||||||
|
Operating (loss) income
|
(
|
|
|
|
|||||||||||||||||||
| Other, net: | |||||||||||||||||||||||
| Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Loss on early redemption of senior unsecured notes |
|
|
|
(
|
|||||||||||||||||||
| Other expense, net |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Total other, net |
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
(Loss) Income before provision for income taxes
|
(
|
|
|
|
|||||||||||||||||||
| Provision for income taxes |
(
|
|
|
|
|||||||||||||||||||
| Net (loss) income | $ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Basic (loss) earnings per common share
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Weighted-average common shares outstanding |
|
|
|
|
|||||||||||||||||||
|
Diluted (loss) earnings per common share
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Weighted-average common shares outstanding |
|
|
|
|
|||||||||||||||||||
| Twelve Weeks Ended | Forty Weeks Ended | ||||||||||||||||||||||
| October 7, 2023 | October 8, 2022 | October 7, 2023 | October 8, 2022 | ||||||||||||||||||||
| Net (loss) income | $ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Other comprehensive loss:
|
|||||||||||||||||||||||
|
Changes in net unrecognized other postretirement benefits, net of tax (benefit) expense of $(
|
(
|
(
|
|
(
|
|||||||||||||||||||
| Currency translation adjustments |
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Total other comprehensive loss
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Comprehensive (loss) income | $ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Advance Auto Parts, Inc. and Subsidiaries
Condensed Consolidated Statements of Changes in Stockholders’ Equity
(in thousands, except per share data) (Unaudited)
|
|||||||||||||||||||||||||||||||||||||||||
|
Twelve Weeks Ended October 7, 2023
|
|||||||||||||||||||||||||||||||||||||||||
| Common Stock |
Additional
Paid-in Capital |
Treasury Stock, at Cost |
Accumulated Other
Comprehensive Loss |
Retained Earnings |
Total
Stockholders’ Equity |
||||||||||||||||||||||||||||||||||||
| Shares | Amount | ||||||||||||||||||||||||||||||||||||||||
| Balance at July 15, 2023 |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||
|
Total other comprehensive loss
|
— | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||
| Restricted stock units and deferred stock units vested |
|
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
| Share-based compensation | — | — |
|
— | — | — |
|
||||||||||||||||||||||||||||||||||
| Stock issued under employee stock purchase plan |
|
— |
|
— | — | — |
|
||||||||||||||||||||||||||||||||||
| Repurchases of common stock |
(
|
— | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||
|
Cash dividends declared ($
|
— | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||
| Balance at October 7, 2023 |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||
|
Twelve Weeks Ended October 8, 2022
|
|||||||||||||||||||||||||||||||||||||||||
| Common Stock |
Additional
Paid-in Capital |
Treasury Stock, at Cost |
Accumulated Other
Comprehensive Loss |
Retained Earnings |
Total
Stockholders’ Equity |
||||||||||||||||||||||||||||||||||||
| Shares | Amount | ||||||||||||||||||||||||||||||||||||||||
| Balance at July 16, 2022 |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||
| Net income | — | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||||
| Total other comprehensive loss | — | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||
| Issuance of shares upon the exercise of stock options |
|
— |
|
— | — | — |
|
||||||||||||||||||||||||||||||||||
| Restricted stock units and deferred stock units vested |
|
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
| Share-based compensation | — | — |
|
— | — | — |
|
||||||||||||||||||||||||||||||||||
| Stock issued under employee stock purchase plan |
|
— |
|
— | — | — |
|
||||||||||||||||||||||||||||||||||
| Repurchases of common stock |
(
|
— | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||
|
Cash dividends declared ($
|
— | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||
| Other | — | — |
(
|
— | — | — |
(
|
||||||||||||||||||||||||||||||||||
| Balance at October 8, 2022 |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||
|
Advance Auto Parts, Inc. and Subsidiaries
Condensed Consolidated Statements of Changes in Stockholders’ Equity
(in thousands, except per share data) (Unaudited)
|
|||||||||||||||||||||||||||||||||||||||||
|
Forty Weeks Ended October 7, 2023
|
|||||||||||||||||||||||||||||||||||||||||
| Common Stock |
Additional
Paid-in Capital |
Treasury Stock, at Cost |
Accumulated Other
Comprehensive Loss |
Retained Earnings |
Total
Stockholders’ Equity |
||||||||||||||||||||||||||||||||||||
| Shares | Amount | ||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2022 |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||
| Net income | — | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||||
|
Total other comprehensive loss
|
— | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||
| Issuance of shares upon the exercise of stock options | — | — |
|
— | — | — |
|
||||||||||||||||||||||||||||||||||
| Restricted stock units and deferred stock units vested |
|
— | — | — | — | — | |||||||||||||||||||||||||||||||||||
| Share-based compensation | — | — |
|
— | — | — |
|
||||||||||||||||||||||||||||||||||
| Stock issued under employee stock purchase plan |
|
— |
|
— | — | — |
|
||||||||||||||||||||||||||||||||||
| Repurchases of common stock |
(
|
— | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||
|
Cash dividends declared ($
|
— | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||
| Other | — | — |
(
|
— | — | — |
(
|
||||||||||||||||||||||||||||||||||
| Balance at October 7, 2023 |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||
|
Forty Weeks Ended October 8, 2022
|
|||||||||||||||||||||||||||||||||||||||||
| Common Stock |
Additional
Paid-in Capital |
Treasury Stock, at Cost |
Accumulated Other
Comprehensive Loss |
Retained Earnings |
Total
Stockholders’ Equity |
||||||||||||||||||||||||||||||||||||
| Shares | Amount | ||||||||||||||||||||||||||||||||||||||||
| Balance at January 1, 2022 |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||
| Net income | — | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||||
| Total other comprehensive loss | — | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||
| Issuance of shares upon the exercise of stock options |
|
— |
|
— | — | — |
|
||||||||||||||||||||||||||||||||||
| Restricted stock units and deferred stock units vested |
|
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
| Share-based compensation | — | — |
|
— | — | — |
|
||||||||||||||||||||||||||||||||||
| Stock issued under employee stock purchase plan |
|
— |
|
— | — | — |
|
||||||||||||||||||||||||||||||||||
| Repurchases of common stock |
(
|
— | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||
|
Cash dividends declared ($
|
— | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||
| Other | — | — |
(
|
— | — | — |
(
|
||||||||||||||||||||||||||||||||||
| Balance at October 8, 2022 |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||
| Forty Weeks Ended | |||||||||||
| October 7, 2023 | October 8, 2022 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income | $ |
|
$ |
|
|||||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|||||||||||
| Depreciation and amortization |
|
|
|||||||||
| Share-based compensation |
|
|
|||||||||
| Loss and impairment of long-lived assets |
|
|
|||||||||
| Loss on early redemption of senior unsecured notes |
|
|
|||||||||
| Provision for deferred income taxes |
(
|
|
|||||||||
| Other, net |
|
|
|||||||||
| Net change in: | |||||||||||
| Receivables, net |
(
|
(
|
|||||||||
| Inventories, net |
(
|
(
|
|||||||||
| Accounts payable |
(
|
|
|||||||||
| Accrued expenses |
|
(
|
|||||||||
| Other assets and liabilities, net |
(
|
(
|
|||||||||
| Net cash provided by operating activities |
|
|
|||||||||
| Cash flows from investing activities: | |||||||||||
| Purchases of property and equipment |
(
|
(
|
|||||||||
| Proceeds from sales of property and equipment |
|
|
|||||||||
| Net cash used in investing activities |
(
|
(
|
|||||||||
| Cash flows from financing activities: | |||||||||||
| Borrowings under credit facilities |
|
|
|||||||||
| Payments on credit facilities |
(
|
(
|
|||||||||
| Borrowings on senior unsecured notes |
|
|
|||||||||
| Payments on senior unsecured notes |
|
(
|
|||||||||
| Dividends paid |
(
|
(
|
|||||||||
| Repurchases of common stock |
(
|
(
|
|||||||||
| Other, net |
(
|
|
|||||||||
| Net cash provided by (used in) financing activities |
|
(
|
|||||||||
| Effect of exchange rate changes on cash |
(
|
(
|
|||||||||
| Net increase (decrease) in cash and cash equivalents |
|
(
|
|||||||||
|
Cash and cash equivalents
, beginning of period
|
|
|
|||||||||
|
Cash and cash equivalents
, end of period
|
$ |
|
$ |
|
|||||||
| Non-cash transactions: | |||||||||||
| Accrued purchases of property and equipment | $ |
|
$ |
|
|||||||
| Twelve Weeks Ended | Forty Weeks Ended | ||||||||||||||||||||||
| October 7, 2023 | October 8, 2022 | October 7, 2023 | October 8, 2022 | ||||||||||||||||||||
| Percentage of Sales: | |||||||||||||||||||||||
| Parts and Batteries |
|
% |
|
% |
|
% |
|
% | |||||||||||||||
| Accessories and Chemicals |
|
|
|
|
|||||||||||||||||||
| Engine Maintenance |
|
|
|
|
|||||||||||||||||||
| Other |
|
|
|
|
|||||||||||||||||||
| Total |
|
% |
|
% |
|
% |
|
% | |||||||||||||||
| October 7, 2023 | December 31, 2022 | ||||||||||
| Inventories at first in, first out (“FIFO”), net | $ |
|
$ |
|
|||||||
| Adjustments to state inventories at LIFO |
(
|
(
|
|||||||||
| Inventories at LIFO, net | $ |
|
$ |
|
|||||||
| October 7, 2023 | December 31, 2022 | ||||||||||
| Trade | $ |
|
$ |
|
|||||||
| Vendor |
|
|
|||||||||
| Other |
|
|
|||||||||
| Total receivables |
|
|
|||||||||
| Less: allowance for credit losses |
(
|
(
|
|||||||||
| Receivables, net | $ |
|
$ |
|
|||||||
| October 7, 2023 | December 31, 2022 | ||||||||||
|
|
$ |
|
$ | — | |||||||
|
|
|
|
|||||||||
|
|
|
— | |||||||||
|
|
|
|
|||||||||
|
|
|
|
|||||||||
|
Revolving credit facility
|
|
|
|||||||||
| $ |
|
$ |
|
||||||||
| Less: Current portion of long-term debt |
|
(
|
|||||||||
| Long-term debt, excluding the current portion | $ |
|
$ |
|
|||||||
| Fair value of long-term debt | $ |
|
$ |
|
|||||||
| Twelve Weeks Ended | Forty Weeks Ended | ||||||||||||||||||||||
| October 7, 2023 | October 8, 2022 | October 7, 2023 | October 8, 2022 | ||||||||||||||||||||
| Operating lease cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Variable lease cost |
|
|
|
|
|||||||||||||||||||
| Total lease cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Forty Weeks Ended | |||||||||||
| October 7, 2023 | October 8, 2022 | ||||||||||
| Cash paid for amounts included in the measurement of lease liabilities: | |||||||||||
| Operating cash flows from operating leases | $ |
|
$ |
|
|||||||
| Right-of-use assets obtained in exchange for lease obligations: | |||||||||||
| Operating leases | $ |
|
$ |
|
|||||||
| Twelve Weeks Ended | Forty Weeks Ended | ||||||||||||||||||||||
| October 7, 2023 | October 8, 2022 | October 7, 2023 | October 8, 2022 | ||||||||||||||||||||
| Numerator | |||||||||||||||||||||||
|
Net (loss) income applicable to common shares
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Denominator | |||||||||||||||||||||||
| Basic weighted-average common shares |
|
|
|
|
|||||||||||||||||||
| Dilutive impact of share-based awards |
|
|
|
|
|||||||||||||||||||
|
Diluted weighted-average common shares
(1)
|
|
|
|
|
|||||||||||||||||||
|
Basic (loss) earnings per common share
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Diluted (loss) earnings per common share
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Twelve Weeks Ended | Forty Weeks Ended | |||||||||||||
| October 7, 2023 | October 7, 2023 | |||||||||||||
|
Risk-free interest rate
(1)
|
|
% |
|
- |
|
% | ||||||||
|
Expected term
(2)
|
|
|
||||||||||||
|
Expected volatility
(3)
|
|
% |
|
- |
|
% | ||||||||
|
Expected dividend yield
(4)
|
|
% |
|
- |
|
% | ||||||||
|
Condensed Consolidated Balance Sheet
|
|||||||||||||||||
| October 8, 2022 | |||||||||||||||||
| As Previously Reported | Adjustments |
As Corrected
|
|||||||||||||||
| Assets | |||||||||||||||||
| Receivables, net | $ |
|
$ |
(
|
$ |
|
|||||||||||
| Total current assets |
|
(
|
|
||||||||||||||
| Total assets | $ |
|
$ |
(
|
$ |
|
|||||||||||
| Liabilities and Stockholders’ Equity | |||||||||||||||||
| Accounts payable | $ |
|
$ |
(
|
$ |
|
|||||||||||
| Accrued expenses |
|
|
|
||||||||||||||
| Total current liabilities |
|
(
|
|
||||||||||||||
| Total liabilities |
|
(
|
|
||||||||||||||
| Accumulated other comprehensive loss |
(
|
|
(
|
||||||||||||||
| Retained earnings |
|
(
|
|
||||||||||||||
| Total stockholders’ equity |
|
|
|
||||||||||||||
| Total liabilities and stockholders’ equity | $ |
|
$ |
(
|
$ |
|
|||||||||||
|
Condensed Consolidated Balance Sheet
|
|||||||||||||||||
| December 31, 2022 | |||||||||||||||||
| As Previously Reported | Adjustments |
As Corrected
|
|||||||||||||||
| Assets | |||||||||||||||||
| Inventories, net | $ |
|
$ |
(
|
$ |
|
|||||||||||
| Total current assets |
|
(
|
|
||||||||||||||
| Total assets | $ |
|
$ |
(
|
$ |
|
|||||||||||
| Liabilities and Stockholders’ Equity | |||||||||||||||||
| Accounts payable | $ |
|
$ |
|
$ |
|
|||||||||||
| Accrued expenses |
|
|
|
||||||||||||||
| Total current liabilities |
|
|
|
||||||||||||||
| Total liabilities |
|
|
|
||||||||||||||
| Retained earnings |
|
(
|
|
||||||||||||||
| Total stockholders’ equity |
|
(
|
|
||||||||||||||
| Total liabilities and stockholders’ equity | $ |
|
$ |
(
|
$ |
|
|||||||||||
|
Condensed Consolidated Balance Sheet
|
|||||||||||||||||
| April 22, 2023 | |||||||||||||||||
| As Previously Reported | Adjustments |
As Corrected
|
|||||||||||||||
| Liabilities and Stockholders’ Equity | |||||||||||||||||
| Accounts payable | $ |
|
$ |
|
$ |
|
|||||||||||
| Accrued expenses |
|
(
|
|
||||||||||||||
| Total current liabilities |
|
|
|
||||||||||||||
| Total liabilities |
|
|
|
||||||||||||||
| Retained earnings |
|
(
|
|
||||||||||||||
| Total stockholders’ equity | $ |
|
$ |
(
|
$ |
|
|||||||||||
|
Condensed Consolidated Balance Sheet
|
|||||||||||||||||
| July 15, 2023 | |||||||||||||||||
| As Previously Reported | Adjustments |
As Corrected
|
|||||||||||||||
| Liabilities and Stockholders’ Equity | |||||||||||||||||
| Accounts payable | $ |
|
$ |
|
$ |
|
|||||||||||
| Accrued expenses |
|
(
|
|
||||||||||||||
| Total current liabilities |
|
|
|
||||||||||||||
| Total liabilities |
|
|
|
||||||||||||||
| Retained earnings |
|
(
|
|
||||||||||||||
| Total stockholders’ equity | $ |
|
$ |
(
|
$ |
|
|||||||||||
|
Condensed Consolidated Statements of Operations
|
||||||||||||||||||||||||||
| October 8, 2022 | ||||||||||||||||||||||||||
| Twelve Weeks Ended | Forty Weeks Ended | |||||||||||||||||||||||||
| As Previously Reported | Adjustments |
As Corrected
|
As Previously Reported | Adjustments |
As Corrected
|
|||||||||||||||||||||
| Cost of sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
| Gross profit |
|
(
|
|
|
(
|
|
||||||||||||||||||||
| Selling, general and administrative expenses |
|
|
|
|
|
|
||||||||||||||||||||
| Operating income |
|
(
|
|
|
(
|
|
||||||||||||||||||||
| Other (expense) income, net |
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||
| Total other, net |
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||
| Income before provision for income taxes |
|
|
|
|
(
|
|
||||||||||||||||||||
| Provision for income taxes |
|
|
|
|
(
|
|
||||||||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||
| Basic earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||
| Basic weighted average shares |
|
— |
|
|
— |
|
||||||||||||||||||||
| Diluted earnings per common share | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||
| Diluted weighted average shares |
|
— |
|
|
— |
|
||||||||||||||||||||
|
Condensed Consolidated Statement of Operations
|
|||||||||||||||||
| December 31, 2022 | |||||||||||||||||
| Year Ended | |||||||||||||||||
| As Previously Reported | Adjustments | As Corrected | |||||||||||||||
| Cost of sales | $ |
|
$ |
|
$ |
|
|||||||||||
| Gross profit |
|
(
|
|
||||||||||||||
| Selling, general and administrative expenses |
|
|
|
||||||||||||||
| Operating income |
|
(
|
|
||||||||||||||
| Other (expense) income, net |
(
|
(
|
(
|
||||||||||||||
| Total other, net |
(
|
(
|
(
|
||||||||||||||
| Income before provision for income taxes |
|
(
|
|
||||||||||||||
| Provision for income taxes |
|
(
|
|
||||||||||||||
| Net income | $ |
|
$ |
(
|
$ |
|
|||||||||||
| Basic earnings per share | $ |
|
$ |
(
|
$ |
|
|||||||||||
| Basic weighted average shares |
|
— |
|
||||||||||||||
| Diluted earnings per common share | $ |
|
$ |
(
|
$ |
|
|||||||||||
| Diluted weighted average shares |
|
— |
|
||||||||||||||
|
Condensed Consolidated Statement of Operations
|
|||||||||||||||||
| April 22, 2023 | |||||||||||||||||
| Sixteen Weeks Ended | |||||||||||||||||
| As Previously Reported | Adjustments |
As Corrected
|
|||||||||||||||
| Cost of sales | $ |
|
$ |
|
$ |
|
|||||||||||
| Gross profit |
|
(
|
|
||||||||||||||
| Selling, general and administrative expenses |
|
(
|
|
||||||||||||||
| Operating income |
|
|
|
||||||||||||||
| Income before provision for income taxes |
|
|
|
||||||||||||||
| Provision for income taxes |
|
|
|
||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
|||||||||||
| Basic earnings per share | $ |
|
$ |
|
$ |
|
|||||||||||
| Basic weighted average shares |
|
— |
|
||||||||||||||
| Diluted earnings per common share | $ |
|
$ |
|
$ |
|
|||||||||||
| Diluted weighted average shares |
|
— |
|
||||||||||||||
|
Condensed Consolidated Statements of Operations
|
||||||||||||||||||||||||||
| July 15, 2023 | ||||||||||||||||||||||||||
| Twelve Weeks Ended | Twenty-Eight Weeks Ended | |||||||||||||||||||||||||
| As Previously Reported | Adjustments |
As Corrected
|
As Previously Reported | Adjustments |
As Corrected
|
|||||||||||||||||||||
| Cost of sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
| Gross profit |
|
(
|
|
|
(
|
|
||||||||||||||||||||
| Selling, general and administrative expenses |
|
|
|
|
(
|
|
||||||||||||||||||||
| Operating income |
|
(
|
|
|
|
|
||||||||||||||||||||
| Income before provision for income taxes |
|
(
|
|
|
|
|
||||||||||||||||||||
| Provision for income taxes |
|
(
|
|
|
|
|
||||||||||||||||||||
| Net income | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
| Basic earnings per share | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
| Basic weighted average shares |
|
— |
|
|
— |
|
||||||||||||||||||||
| — | — | |||||||||||||||||||||||||
| Diluted earnings per common share | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
| Diluted weighted average shares |
|
— |
|
|
— |
|
||||||||||||||||||||
|
Condensed Consolidated Statements of Comprehensive Income
|
|||||||||||||||||||||||||||||||||||
| October 8, 2022 | |||||||||||||||||||||||||||||||||||
| Twelve Weeks Ended | Forty Weeks Ended | ||||||||||||||||||||||||||||||||||
| As Previously Reported | Adjustments |
As Corrected
|
As Previously Reported | Adjustments |
As Corrected
|
||||||||||||||||||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
|
Currency translation adjustments
|
(
|
|
(
|
(
|
|
(
|
|||||||||||||||||||||||||||||
|
Total other comprehensive loss
|
(
|
|
(
|
(
|
|
(
|
|||||||||||||||||||||||||||||
| Comprehensive income | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
|
Condensed Consolidated Statement of Comprehensive Income
|
|||||||||||||||||
| December 31, 2022 | |||||||||||||||||
| Year Ended | |||||||||||||||||
| As Previously Reported | Adjustments |
As Corrected
|
|||||||||||||||
| Net income | $ |
|
$ |
(
|
$ |
|
|||||||||||
| Currency translation adjustments |
(
|
|
(
|
||||||||||||||
| Total other comprehensive loss |
(
|
|
(
|
||||||||||||||
| Comprehensive income | $ |
|
$ |
(
|
$ |
|
|||||||||||
|
Condensed Consolidated Statement of Comprehensive Income
|
|||||||||||||||||
| April 22, 2023 | |||||||||||||||||
| Sixteen Weeks Ended | |||||||||||||||||
| As Previously Reported | Adjustments | As Corrected | |||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
|||||||||||
| Comprehensive income | $ |
|
$ |
|
$ |
|
|||||||||||
|
Condensed Consolidated Statements of Comprehensive Income
|
|||||||||||||||||||||||||||||||||||
| July 15, 2023 | |||||||||||||||||||||||||||||||||||
| Twelve Weeks Ended | Twenty-Eight Weeks Ended | ||||||||||||||||||||||||||||||||||
| As Previously Reported | Adjustments |
As Corrected
|
As Previously Reported | Adjustments |
As Corrected
|
||||||||||||||||||||||||||||||
| Net income | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| Comprehensive income | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
|
Condensed Consolidated Statements of Changes in Stockholders’ Equity
|
|||||||||||||||||||||||
|
Accumulated Other
Comprehensive Loss
|
Retained
Earnings |
Total Stockholders' Equity | |||||||||||||||||||||
| Twelve Weeks As Previously Reported | |||||||||||||||||||||||
| Balance at July 16, 2022 | $ |
(
|
$ |
|
$ |
|
|||||||||||||||||
| Net income | — |
|
|
||||||||||||||||||||
|
Total other comprehensive loss
|
(
|
— |
(
|
||||||||||||||||||||
| Balance at October 8, 2022 | $ |
(
|
$ |
|
$ |
|
|||||||||||||||||
| Adjustments | |||||||||||||||||||||||
| Balance at July 16, 2022 | $ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||
| Net income | — |
|
|
||||||||||||||||||||
|
Total other comprehensive income
|
|
— |
|
||||||||||||||||||||
| Balance at October 8, 2022 | $ |
|
$ |
(
|
$ |
|
|||||||||||||||||
| As Corrected | |||||||||||||||||||||||
|
Balance at July 16, 2022
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||
| Net income | — |
|
|
||||||||||||||||||||
|
Total other comprehensive loss
|
(
|
— |
(
|
||||||||||||||||||||
| Balance at October 8, 2022 | $ |
(
|
$ |
|
$ |
|
|||||||||||||||||
| Forty Weeks As Previously Reported | |||||||||||||||||||||||
| Balance at January 1, 2022 | $ |
(
|
$ |
|
$ |
|
|||||||||||||||||
| Net income | — |
|
|
||||||||||||||||||||
|
Total other comprehensive loss
|
(
|
— |
(
|
||||||||||||||||||||
| Balance at October 8, 2022 | $ |
(
|
$ |
|
$ |
|
|||||||||||||||||
|
Adjustments
|
|||||||||||||||||||||||
| Balance at January 1, 2022 | $ |
(
|
$ |
|
$ |
|
|||||||||||||||||
| Net income | — |
(
|
(
|
||||||||||||||||||||
|
Total other comprehensive income
|
|
— |
|
||||||||||||||||||||
| Balance at October 8, 2022 | $ |
|
$ |
(
|
$ |
|
|||||||||||||||||
|
As Corrected
|
|||||||||||||||||||||||
| Balance at January 1, 2022 | $ |
(
|
$ |
|
$ |
|
|||||||||||||||||
| Net income | — |
|
|
||||||||||||||||||||
|
Total other comprehensive loss
|
(
|
— |
(
|
||||||||||||||||||||
| Balance at October 8, 2022 | $ |
(
|
$ |
|
$ |
|
|||||||||||||||||
|
Accumulated Other
Comprehensive Loss |
Retained
Earnings |
Total
Stockholders’ Equity |
|||||||||||||||||||||
| Fifty-Two Weeks As Previously Reported | |||||||||||||||||||||||
|
Balance at January 1, 2022
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||
| Net income | — |
|
|
||||||||||||||||||||
|
Total other comprehensive loss
|
(
|
— |
(
|
||||||||||||||||||||
| Balance at December 31, 2022 | $ |
(
|
$ |
|
$ |
|
|||||||||||||||||
| Adjustments | |||||||||||||||||||||||
| Balance at January 1, 2022 | $ |
(
|
$ |
|
$ |
|
|||||||||||||||||
| Net Income | — |
(
|
(
|
||||||||||||||||||||
|
Total other comprehensive income
|
|
— |
|
||||||||||||||||||||
| Balance at December 31, 2022 | $ | — | $ |
(
|
$ |
(
|
|||||||||||||||||
| As Corrected | |||||||||||||||||||||||
|
Balance at January 1, 2022
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||
| Net income | — |
|
|
||||||||||||||||||||
|
Total other comprehensive loss
|
(
|
— |
(
|
||||||||||||||||||||
| Balance at December 31, 2022 | $ |
(
|
$ |
|
$ |
|
|||||||||||||||||
|
Retained
Earnings |
Total
Stockholders’ Equity |
||||||||||||||||||||||
| Sixteen Weeks As Previously Reported | |||||||||||||||||||||||
| Balance at December 31, 2022 | $ |
|
$ |
|
|||||||||||||||||||
| Net Income |
|
|
|||||||||||||||||||||
|
Balance at April 22, 2023
|
$ |
|
$ |
|
|||||||||||||||||||
| Adjustments | |||||||||||||||||||||||
| Balance at December 31, 2022 | $ |
(
|
$ |
(
|
|||||||||||||||||||
| Net Income |
|
|
|||||||||||||||||||||
|
Balance at April 22, 2023
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
| As Corrected | |||||||||||||||||||||||
| Balance at December 31, 2022 | $ |
|
$ |
|
|||||||||||||||||||
| Net Income |
|
|
|||||||||||||||||||||
|
Balance at April 22, 2023
|
$ |
|
$ |
|
|||||||||||||||||||
|
Retained
Earnings |
Total
Stockholders’ Equity |
||||||||||||||||||||||
|
Twelve Weeks As Previously Reported
|
|||||||||||||||||||||||
|
Balance at April 22, 2023
|
$ |
|
$ |
|
|||||||||||||||||||
| Net Income |
|
|
|||||||||||||||||||||
|
Balance at July 15, 2023
|
$ |
|
$ |
|
|||||||||||||||||||
| Adjustments | |||||||||||||||||||||||
|
Balance at April 22, 2023
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
| Net Income |
(
|
(
|
|||||||||||||||||||||
|
Balance at July 15, 2023
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
| As Corrected | |||||||||||||||||||||||
| Balance at April 22, 2023 | $ |
|
$ |
|
|||||||||||||||||||
| Net Income |
|
|
|||||||||||||||||||||
|
Balance at July 15, 2023
|
$ |
|
$ |
|
|||||||||||||||||||
|
Twenty-Eight Weeks As Previously Reported
|
|||||||||||||||||||||||
| Balance at December 31, 2022 | $ |
|
$ |
|
|||||||||||||||||||
| Net Income |
|
|
|||||||||||||||||||||
| Balance at July 15, 2023 | $ |
|
$ |
|
|||||||||||||||||||
| Adjustments | |||||||||||||||||||||||
| Balance at December 31, 2022 | $ |
(
|
$ |
(
|
|||||||||||||||||||
| Net Income |
|
|
|||||||||||||||||||||
| Balance at July 15, 2023 | $ |
(
|
$ |
(
|
|||||||||||||||||||
| As Corrected | |||||||||||||||||||||||
| Balance at December 31, 2022 | $ |
|
$ |
|
|||||||||||||||||||
|
Net Income
|
|
|
|||||||||||||||||||||
|
Balance at July 15, 2023
|
$ |
|
$ |
|
|||||||||||||||||||
| Condensed Consolidated Statement of Cash Flows | |||||||||||||||||
| Forty Weeks Ended October 8, 2022 | |||||||||||||||||
| As Previously Reported | Adjustments | As Corrected | |||||||||||||||
| Net income | $ |
|
$ |
(
|
$ |
|
|||||||||||
| Net change in: | |||||||||||||||||
| Receivables, net |
(
|
(
|
(
|
||||||||||||||
| Inventories, net |
(
|
|
(
|
||||||||||||||
| Accounts payable |
|
(
|
|
||||||||||||||
| Accrued expenses | $ |
(
|
$ |
|
$ |
(
|
|||||||||||
| Condensed Consolidated Statement of Cash Flows | |||||||||||||||||
| Fifty-Two Weeks Ended December 31, 2022 | |||||||||||||||||
| As Previously Reported | Adjustments | As Corrected | |||||||||||||||
| Net income | $ |
|
$ |
(
|
$ |
|
|||||||||||
| Net change in: | |||||||||||||||||
| Receivables, net |
|
(
|
|
||||||||||||||
| Inventories, net |
(
|
|
(
|
||||||||||||||
| Accounts payable |
|
|
|
||||||||||||||
| Accrued expenses | $ |
(
|
$ |
|
$ |
(
|
|||||||||||
| Condensed Consolidated Statement of Cash Flows | |||||||||||||||||
| Sixteen Weeks Ended April 22, 2023 | |||||||||||||||||
| As Previously Reported | Adjustments | As Corrected | |||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
|||||||||||
| Net change in: | |||||||||||||||||
| Inventories, net |
(
|
(
|
(
|
||||||||||||||
| Accounts payable |
(
|
|
(
|
||||||||||||||
| Accrued expenses | $ |
|
$ |
(
|
$ |
|
|||||||||||
| Condensed Consolidated Statement of Cash Flows | |||||||||||||||||
| Twenty-Eight Weeks ended July 15, 2023 | |||||||||||||||||
| As Previously Reported | Adjustments | As Corrected | |||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
|||||||||||
| Net change in: | |||||||||||||||||
| Inventories, net |
(
|
(
|
(
|
||||||||||||||
| Accounts payable |
(
|
|
(
|
||||||||||||||
| Accrued expenses | $ |
|
$ |
(
|
$ |
|
|||||||||||
|
Twelve Weeks Ended
|
$ Favorable/ (Unfavorable) | Basis Points | |||||||||||||||||||||||||||||||||
| ($ in millions) | October 7, 2023 |
October 8, 2022
(1)
|
|||||||||||||||||||||||||||||||||
| Net sales | $ | 2,719.1 | 100.0 | % | $ | 2,641.3 | 100.0 | % | $ | 77.8 | — | ||||||||||||||||||||||||
| Cost of sales | 1,732.4 | 63.7 | 1,462.1 | 55.4 | (270.3) | (836) | |||||||||||||||||||||||||||||
| Gross profit | 986.7 | 36.3 | 1,179.2 | 44.6 | (192.5) | (836) | |||||||||||||||||||||||||||||
| SG&A | 1,030.4 | 37.9 | 1,008.2 | 38.2 | (22.2) | 28 | |||||||||||||||||||||||||||||
|
Operating (loss) income
|
(43.7) | (1.6) | 171.0 | 6.5 | (214.7) | (808) | |||||||||||||||||||||||||||||
| Interest expense | (19.4) | (0.7) | (12.0) | (0.5) | (7.4) | (26) | |||||||||||||||||||||||||||||
|
Other expense, net
|
(1.2) | 0.0 | (5.1) | (0.2) | 3.9 | 15 | |||||||||||||||||||||||||||||
|
Provision for income taxes
|
(15.7) | (0.6) | 38.0 | 1.4 | 53.7 | 202 | |||||||||||||||||||||||||||||
|
Net (loss) income
|
$ | (48.6) | (1.8) | % | $ | 115.9 | 4.4 | % | $ | (164.5) | (617) | ||||||||||||||||||||||||
| Forty Weeks Ended | $ Favorable/ (Unfavorable) | Basis Points | |||||||||||||||||||||||||||||||||
| ($ in millions) | October 7, 2023 |
October 8, 2022
(1)
|
|||||||||||||||||||||||||||||||||
| Net sales | $ | 8,822.7 | 100.0 | % | $ | 8,681.0 | 100.0 | % | $ | 141.7 | — | ||||||||||||||||||||||||
| Cost of sales | 5,220.2 | 59.2 | 4,821.0 | 55.5 | (399.2) | (363) | |||||||||||||||||||||||||||||
| Gross profit | 3,602.5 | 40.8 | 3,860.0 | 44.5 | (257.5) | (363) | |||||||||||||||||||||||||||||
|
SG&A
|
3,407.4 | 38.6 | 3,302.0 | 38.0 | (105.4) | (58) | |||||||||||||||||||||||||||||
| Operating income | 195.1 | 2.2 | 558.0 | 6.4 | (362.9) | (422) | |||||||||||||||||||||||||||||
| Interest expense | (70.0) | (0.8) | (35.1) | (0.4) | (34.9) | (39) | |||||||||||||||||||||||||||||
| Loss on early redemptions of senior unsecured notes | — | 0.0 | (7.4) | (0.1) | 7.4 | 9 | |||||||||||||||||||||||||||||
|
Other expense, net
|
(0.2) | 0.0 | (5.3) | (0.1) | 5.1 | 6 | |||||||||||||||||||||||||||||
| Provision for income taxes | 34.6 | 0.4 | 123.4 | 1.4 | 88.8 | 103 | |||||||||||||||||||||||||||||
| Net income | $ | 90.2 | 1.0 | % | $ | 386.8 | 4.5 | % | $ | (296.5) | (343) | ||||||||||||||||||||||||
| Forty Weeks Ended | |||||||||||
| (in thousands) | October 7, 2023 |
October 8, 2022
(1)
|
|||||||||
| Cash flows provided by operating activities | $ | 30,404 | $ | 483,094 | |||||||
| Cash flows used in investing activities | (185,200) | (331,818) | |||||||||
| Cash flows provided by (used in) financing activities | 204,984 | (545,838) | |||||||||
| Effect of exchange rate changes on cash | (1,942) | (15,662) | |||||||||
| Net increase (decrease) in cash and cash equivalents | $ | 48,246 | $ | (410,224) | |||||||
|
Total Number of Shares Purchased
(1)
|
Average Price Paid per Share
(1)
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in thousands) | |||||||||||||||||||||||
| July 16, 2023 to August 12, 2023 | 50 | $ | 73.05 | — | $ | 947,338,896 | ||||||||||||||||||||
| August 13, 2023 to September 9, 2023 | 6,272 | $ | 67.77 | — | $ | 947,338,896 | ||||||||||||||||||||
| September 10, 2023 to October 7, 2023 | 6 | $ | 57.60 | — | $ | 947,338,896 | ||||||||||||||||||||
| Total | 6,328 | $ | 67.80 | — | ||||||||||||||||||||||
| Incorporated by Reference | ||||||||||||||
| Exhibit No. | Exhibit Description | Form | Exhibit | Filing Date | ||||||||||
| 10-Q | 3.1 | 8/14/2018 | ||||||||||||
| 8-K | 3.2 | 8/14/2023 | ||||||||||||
| 8-K | 10.1 | 8/23/2023 | ||||||||||||
| 8-K | 10.1 | 8/23/2023 | ||||||||||||
| 8-K | 10.1 | 8/23/2023 | ||||||||||||
| 10-Q | 10.1 | 8/23/2023 | ||||||||||||
|
*
|
*
|
*
|
||||||||||||
| 10-Q | 22.1 | 8/23/2023 | ||||||||||||
|
31.1
*
|
||||||||||||||
|
31.2
*
|
||||||||||||||
|
32.1
**
|
||||||||||||||
| 101.INS* | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |||||||||||||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document. | |||||||||||||
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |||||||||||||
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |||||||||||||
| 101.LAB* | Inline XBRL Taxonomy Extension Labels Linkbase Document. | |||||||||||||
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |||||||||||||
| 104.1* | Cover Page Interactive Data file (Embedded within Inline XBRL Documents and Included in Exhibit 101). | |||||||||||||
| ADVANCE AUTO PARTS, INC. | ||||||||
| Date: November 21, 2023 | /s/ Anthony A. Iskander | |||||||
|
Anthony A. Iskander
Interim Chief Financial Officer, Senior Vice President, Finance and Treasurer |
||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|